Food industry veterans, including former CSOs at Mars and General Mills, are pooling capital through a new UC Davis angel network, Food & Health Angels (FH Angels), to back early-stage foodtech startups.
“With 92% of Americans considered metabolically unhealthy and GLP-1 use growing, the need for science-backed solutions has never been more urgent,” said founding director Kim Fisher.
“From AI-driven discovery to new sensor technologies, to the ability to deliver precision nutrition, the pace of innovative companies coming out of UC Davis and across the country is staggering. We’re making it easier to get in on the ground floor of great companies by pooling capital, with a low minimum requirement [$10,000] for investing.”
Beyond capital, FH Angels will provide founders with guidance and connections, Fisher told AgFunderNews on the sidelines of the Future Food-Tech conference in San Francisco last week.
“With the advent of GLP-1s and other incretin hormones [such as GIP] that I think are going to be an absolute tsunami as these drugs come off patent, and we have oral medications that are easier to take, this is going to continue to drive food and health innovation. And so we thought the timing was right to start investing in companies innovating in this space.”
She added: “At UC Davis, big CPGs such as Nestle and OFI and Mars are partnering with us because they see the writing on the wall and they want to build healthier companies, but they are also interested in startups coming out of Davis and elsewhere.”
Checks from $100k to $5m
Fisher clarified: “FH Angels is not a fund. We’re starting with 25 charter members, and they will invest their individual money, but it will be pooled into a special purpose vehicle, so for the startup, it’s really easy, it just looks like one chunk of money.
“For the angels, it’s really easy too. We have a lot of people who are able to put million-dollar checks into companies, but we’re also making it available to people who can only put in $10,000.”
FH Angels is looking at firms that are “beyond the concept stage,” she said. “And they need to have IP or some kind of competitive moat. We are looking for technology- and science-backed companies that can improve healthy longevity and metabolic health. A lot of the companies we’ve seen so far are revenue positive, but they’re not yet profitable. So we’re talking pre-venture capital, but post grant/lab phase.”
She added: “We’re looking at investing anywhere from $100,000 to $5 million and we might co invest with some seed venture capitalists that we’re partnered with and other angel networks. Each individual might put in a $10,000 check or a half a million dollar check, but we’ll pool the capital and make it really simple on the cap table for the startup.”
Democratizing precision nutrition
While Fisher said diet and lifestyle changes are key to improving metabolic health, she argued that new tools—from non-invasive glucose biosensors to tech measuring hormones and proteins in the blood—can help people better understand how food interventions impact their health.
“Right now, people are saying just eat more protein, but it’s not very nuanced conversation. So one startup out of UC Davis, Amplifye, for example [which designs enzymes to increase protein absorption] looks at how much of that protein is being used for muscle synthesis. If we could measure how nutrients we consume are really getting used, it could really inform what we eat, so I think sensing is a really big area we’ll be looking at investing in.
“We’re also looking at investing in food as medicine platforms. So, it might be figuring out exactly what your family’s different needs are and get food delivered that fits those needs. Can we better understand our own gut microbiome? Are we getting the nutrition we need if we are taking GLP-1s?
“But I want to see this democratized, and I agree, precision nutrition needs to be something that can be [instituted] population wide [if it is to move the needle on public health].”
FH Angels
FH Angels invests in early-stage global companies that apply science, data, and technology to improve metabolic health, performance, and healthy longevity. International companies must create a US entity. It is looking for:
Ingredient and product innovation: Next-gen bioactives, fermented ingredients, and AI-assisted formulation platforms turning molecular science into scalable foods.
Metabolic health solutions: Biosensors, data platforms, and “food-as-medicine” programs integrating nutrition into healthcare and daily decision-making.
Membership criteria for investors:
- Accredited investor: $1million+ net worth or $200k+ income
- Annual fee: $3,500 (individual) / $20,000 (VC firms)
- Active participation: Attend events, help screen, or source deals
Structure and benefits:
- Access to a curated pipeline of high-quality startups
- Investment meet-ups and dinners with faculty/researchers/investors/startups
- Invest via SPVs (LLCs) per deal. Low minimums ($10K/deal)
- Rigorous due diligence provided by the screening committee
